Clinical Trial

MBT-early: a Single Case Experimental Design

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 15, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Borderline personality disorder (BPD) is characterized by problems in emotion regulation, identity disturbances, and impaired interpersonal functioning. Because BPD may determine health and quality of life in long term, it is important to focus on early detection and early intervention to prevent worsening. In this study, the effectiveness of a new intervention, MBT-early, is investigated in adolescents with borderline personality problems, using a single-case experimental design (SCED). V1.0 Initial release - \[13/12/2023\]: Initial registration. V1.1 2 Amendments - \[14-07-2025\]: * (1) Amendment to to clarify the use of diagnostic data (SCID-5-S) for inclusion purposes and to add logbooks documenting deviations from standard treatment protocols. Approved by the METC on 22-10-2024. * (2) Amendment to include to expand the sample size from 6 to 8 participants and to include a qualitative component involving semi-structured interviews with participants, their caregivers, and therapists. Approved by the METC on 23-01-2025.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-01-09; most recent amendment 2025-07-14.
Status change: Recruiting → Active, Not Recruiting 2025-07-14
Status change: Not Yet Recruiting → Recruiting 2024-07-09
Trial Details
NCT Number NCT06212024
Lead Sponsor De Viersprong
Conditions Borderline Personality Disorder
Enrollment 8 participants
Start Date 2024-03-27
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-07-15